EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR IN PERSONS WITH DEVELOPMENTAL DISABILITIES: II. SOCIAL VALIDITY MEASURES
Saved in:
MCADAM, D.B., ET AL., EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR IN PERSONS WITH DEVELOPMENTAL DISABILITIES: II. SOCIAL VALIDITY MEASURES. AMERICAN JOURNAL ON MENTAL RETARDATION, Vol. 107, no. 4 (2002), p. 261-269.
Ref.
114832
Location:
SIIS R.100 Archivo
Palabras clave:
Discapacidad intelectual, Fármacos, Resultados, Trastornos de la conducta, Tratamiento
Discapacidad intelectual, Fármacos, Resultados, Trastornos de la conducta, Tratamiento
Similar Items: EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR IN PERSONS WITH DEVELOPMENTAL DISABILITIES: II. SOCIAL VALIDITY MEASURES
- EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR OF PERSONS WITH DEVELOPMENTAL DISABILITIES: I. A DOUBLE-BLIND CROSSOVER STUDY USING MULTIPLE MEASURES
- EFFECTS OF RISPERIDONE ON DESTRUCTIVE BEHAVIOR OF PERSONS WITH DEVELOPMENTAL DISABILITIES: III. FUNCTIONAL ANALYSIS
- RISPERIDONE FOR SEVERELY DISTURBED BEHAVIOR AND TARDIVE DYSKINESIA IN DEVELOPMENTALLY DISABLED ADULTS
- USING THE DIAGNOSTIC ASSESSMENT OF THE SEVERELY HANDICAPPED-II (DASH-II) TO MEASURE THE THERAPEUTIC EFFECTS OF RISPERIDONE
- EFFECTS OF CLOZAPINE ON SELF-INJURIOUS BEHAVIOR OF TWO RISPERIDONE NONRESPONDERS WITH MENTAL RETARDATION
- COMMUNICATION DEVELOPMENT AND ABERRANT BEHAVIOR IN CHILDREN WITH DEVELOPMENTAL DISABILITIES